Jennifer Dawn Smith, CNM - Advanced Practice Midwife in Jber, AK

Jennifer Dawn Smith, CNM is a Advanced Practice Midwife based in Jber, Alaska. Jennifer Dawn Smith is licensed to practice in Ohio (license number RN.324909) and her current practice location is 5955 Zeamer Ave, Jber, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 580-5808.

NPI number for Jennifer Dawn Smith is 1750905154 and her current mailing address is 5955 Zeamer Ave, Jber, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1750905154.

Contact Information

Jennifer Dawn Smith, CNM
5955 Zeamer Ave,
Jber, AK 99506-3702
(907) 580-5808
Not Available



Provider's Profile

Full NameJennifer Dawn Smith
GenderFemale
SpecialityAdvanced Practice Midwife
Location5955 Zeamer Ave, Jber, Alaska
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1750905154
  • Provider Enumeration Date: 06/01/2020
  • Last Update Date: 06/21/2021

Medical Identifiers

Medical identifiers for Jennifer Dawn Smith such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1750905154NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367A00000XAdvanced Practice Midwife RN.324909 (Ohio)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jennifer Dawn Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jennifer Dawn Smith, CNM
5955 Zeamer Ave,
Jber, AK 99506-3702

Ph: (907) 580-5808
Jennifer Dawn Smith, CNM
5955 Zeamer Ave,
Jber, AK 99506-3702

Ph: (907) 580-5808

News Archive

NeuroDerm receives $1M grant for development of ND0611 dermal patch for Parkinson's disease

NeuroDerm, Ltd. was informed today that it was awarded a grant of $1M by The Michael J. Fox Foundation for Parkinson's Research. These funds will support the next clinical study with ND0611, a new dermal patch for the treatment of Parkinson's disease, as part of the Foundation's prestigious Clinical Intervention Awards 2010 program. This study will evaluate the safety, tolerability, levodopa pharmacokinetics, and possible clinical benefits of ND0611 in advanced Parkinson's disease patients.

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

HIV is a moving target, unpredictably changing direction to elude anti-AIDS drugs, but researchers at Rutgers are clearly on the track of solutions to combat HIV drug resistance.

States continue to react to health reform's high-risk insurance pools, individual insurance requirement

"Gov. Jan. Brewer told the Obama administration that Arizona can't afford an insurance program that would extend health coverage to Arizonans unable to purchase insurance because of pre-existing medical conditions. Arizona is among 19 states that have rejected federal funds to administer a high-risk insurance pool. That means the federal government will create and run such a pool on behalf of Arizona and the other states that have declined participation" (Alltucker, 5/5).

Survey: 44% of German women do not play sport or spend any time on intensive workouts

A new survey reveals that 44 per cent of German women did not play competitive sport or spend any time on intensive workouts such as running or cycling, in a given week. German women remain reluctant to devote any time to competitive sport, despite being more physically active than their European counterparts in Britain, Denmark, Sweden and France, according to a new multi-national survey on sport and exercise habits.

MUSC researchers provide first systemic evidence for safe use of tPA in stroke patients with SCD

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, report investigators at the Medical University of South Carolina and elsewhere in the March 2017 issue of Stroke.

Read more News

› Verified 7 days ago


Advanced Practice Midwife Nurses in Jber, AK

Stephanie Shivers, CNM/ARNP
Advanced Practice Midwife
Medicare: Medicare Enrolled
Practice Location: 5955 Zeamer Ave, Jber, AK 99506
Phone: 907-580-5808    
Angela C Gookin, CNM
Advanced Practice Midwife
Medicare: Medicare Enrolled
Practice Location: 5955 Zeamer Ave, 673d Mdg, Jber, AK 99506
Phone: 907-580-4016    Fax: 907-580-1373

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.